MedTrace Logo

Efficacy and Safety of Imuneks 10 mg Capsules in the Prophylaxis of Cold

NCT02807220 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2017-05-03

No results posted yet for this study

Summary

The objective of this study is to evaluate the efficacy and safety of Imuneks 10 mg Capsules in the prophylaxis of cold and the maintenance of the good health state in 70 healthy subjects.

Conditions

  • Cold Symptoms

Interventions

DRUG

Imuneks 10mg

Two capsules of the study drug every morning approximately two hours after breakfast for six weeks

Sponsors & Collaborators

  • TC Erciyes University

    collaborator OTHER

  • Imuneks Farma ilac San. Tic. A.S.

    lead INDUSTRY

Principal Investigators

  • Ahmet İnal, Asst. Prof. · Erciyes University Hakan Çetinsaya İKU Merkezi (Center for GCP)

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-27
Primary Completion
2017-04-13
Completion
2017-04-13

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02807220 on ClinicalTrials.gov